Fact CheckerSign in

NCT06954571Active, not recruiting

Imaging-Guided Classification for Endophytic Renal Tumors: PN Strategies & Outcomes

A Novel Imaging-Guided Classification System for Completely Endophytic Renal Tumors: Strategies for Optimal Partial Nephrectomy and Clinical Outcome Comparison

Source: ClinicalTrials.gov · Last updated 11 May 2025

Brief summary (registry, in English)

Study Title: Imaging-Guided Classification \& Surgical Outcomes in Endophytic Renal Tumors Study Goal: This observational study investigates whether an imaging-guided classification system improves partial nephrectomy (PN) outcomes for completely endophytic renal cell carcinoma (RCC). Main Question: Does preoperative imaging classification reduce complications (e.g., ischemia time, urinary leakage) in PN for endophytic RCC compared to traditional methods? Methods: Patients undergoing PN for endophytic RCC will be grouped based on preoperative imaging classification. Surgical outcomes (complications, renal function) will be tracked for 5 years and compared to non-classified PN cases. Significance: Aims to optimize PN planning, minimize risks, and improve long-term renal preservation in complex RCC cases

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
190 (actual)
First submitted
16 Apr 2025
Start date
1 Jan 2018
Primary completion date
30 Nov 2024
Lead sponsor
Tianjin Medical University Second Hospital
NCT number
NCT06954571

What you commit to

  • Study type: Observational
  • Participants enrolled: 190
  • From 1 Jan 2018 to the primary completion date, 30 Nov 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients with unilateral multiple renal tumors , solitary kidney , or comorbid severe medical conditions;

Other

  • Patients without clinicopathologic, functional or prognosis data;

Who the study is looking for

  • Patients who completed partial resection of completely endogenous renal cancer from January 2018 to November 2024 at the Second Hospital of Tianjin Medical University;
  • Older than 18 years.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
The Second Hospital of Tianjin Medical University
Coordinator of this site? Confirm its status
TianjinChinaUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.